To include your compound in the COVID-19 Resource Center, submit it here.

Erbitux cetuximab: Phase III started

MRK began the European, Latin American and Asian EMR-046 Phase

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE